Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome.

× No keyword cloud information.

7 in total

1. Gaucher disease plus.

Authors: E Sidransky; E I Ginns
Journal: J Med Genet Date: 1997-10 Impact factor: 6.318

2. Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy.

Authors: Sarah Michelman Lo; Jun Liu; F Chen; G M Pastores; J Knowles; M Boxer; Kirk Aleck; Pramod K Mistry
Journal: J Inherit Metab Dis Date: 2011-03-29 Impact factor: 4.982

3. Echocardiographic Assessment of Left Ventricular Function in Type 1 Gaucher's Disease.

Authors: Mirta Kozelj; Samo Zver; Vesna Zadnik
Journal: Adv Hematol Date: 2010-07-20

Review 4. Gaucher disease and the clinical experience with substrate reduction therapy.

Authors: Ari Zimran; Deborah Elstein
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2003-05-29 Impact factor: 6.237

5. Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation.

Authors: Chun-An Chen; Nelson L S Tang; Yin-Hsiu Chien; Wei-Min Zhang; Jou-Kou Wang; Wuh-Liang Hwu
Journal: BMC Med Genet Date: 2005-06-09 Impact factor: 2.103

6. Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy.

Authors: Amal El Beshlawy; Vagishwari Murugesan; Pramod Kumar Mistry; Khaled Eid
Journal: Mol Genet Metab Rep Date: 2019-06-28

Review 7. Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors: Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal: Front Med (Lausanne) Date: 2021-03-25

7 in total